AllCells Opens a New Collection Facility in Houston, Texas

Expanding Its Donor Network

AllCells, the leading provider of human hematological products and services, is pleased to announce the opening of a new, 3600 sq ft LeukoLab cell collection facility in Houston, Texas. The new LeukoLab facility will support biomedical research regionally, domestically, and globally for sourcing mobilized peripheral blood, apheresis starting materials, and donor management services.

The Houston LeukoLab facility is strategically located next to the University of Houston, greatly expanding AllCells’ diverse donor network. This central location is key to providing faster delivery options to clients, as well as increasing AllCells’ Sickle Cell program capabilities. Same-day and next-day delivery will be offered to support researchers’ timelines.

LeukoLab is a division of AllCells and oversees donor management, recruitment, and retention services. In addition to managing a quality donor pool, LeukoLab also developed an in-house proprietary database known as DMS (Donor Management System). DMS provides AllCells clients with a targeted approach on specific donor requirements to get suitable donors for every project – every time.

“The opening of the AllCells’ Houston facility gives us the opportunity to leverage an expanded donor network with increased cell collection and processing capabilities to meet the strong market demand. The facility also is in close proximity to clients to support their research partners. AllCells’ ability to adapt to market trends, coupled with premium customer service, puts us in the best position to support our partners in achieving their program goals, faster than ever before.” – Danny Zheng, President and CEO of AllCells.